Martin Babler
CEO of Principia BioPharma & Alumis
Contact
- Social accounts: linkedin
Companies
Company
Roles
Principia BioPharma
A biopharmaceutical company developing oral small molecule therapies for the treatment of cancer and autoimmune diseases
CEO
Alumis
Alumis Inc. is a precision medicine company with the mission to transform the lives of patients with autoimmune diseases.
CEO
Neoleukin Therapeutics (Aquinox)
Company develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology.
Board Member
Prelude Therapeutics
Prelude Therapeutics is a cancer Treatments founded in 2016.
Board Member